Page last updated: 2024-08-23

daunorubicin and HIV Coinfection

daunorubicin has been researched along with HIV Coinfection in 18 studies

Research

Studies (18)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	12 (66.67)	18.2507
2000's	4 (22.22)	29.6817
2010's	2 (11.11)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bendle, M; Bower, M; Papanastasopoulos, P; Pealing, J	1
Burns, A; Davidson, RN; Gow, NJ; Thomas, MG; Ticehurst, R	1
Oksenhendler, E	1
Ghosh, K; Gupta, M; Jijina, F; Madkaikar, M; Mohanty, D; Rajpurkar, M	1
Forteza, AM; Koch, S; Ortiz, G; Rabinstein, AA; Romano, JG	1
Kane, D; Keating, S; McCann, S; Mulcahy, F	1
White, RM	1
Goebel, FD; Jablonowski, H	1
Bennett, C; Hjortsberg, C; Lidbrink, E; Persson, U	1
Pozo, F; Rivero, A; Serrano, R; Tenorio, A; Torre-Cisneros, J; Vidal, E	1
Wernz, JC	1
Link, D	1

Reviews

2 review(s) available for daunorubicin and HIV Coinfection

Article	Year
HIV-associated multicentric Castleman disease. Current opinion in HIV and AIDS, 2009, Volume: 4, Issue:1 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Asparaginase; Castleman Disease; Clinical Trials as Topic; Cytarabine; Daunorubicin; Etoposide; Ganciclovir; Herpesviridae Infections; Herpesvirus 8, Human; HIV Infections; Humans; Lymph Nodes; Rituximab; Thioguanine; Valganciclovir; Virus Replication	2009
The management of acute myeloid leukaemia (AML) in human immunodeficiency virus (HIV) infection: a case report and review. International journal of STD & AIDS, 1997, Volume: 8, Issue:4 Topics: Adult; Anti-HIV Agents; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Cytarabine; Daunorubicin; Drug Therapy, Combination; HIV Infections; Humans; Leukemia, Myeloid, Acute; Male; Thioguanine; Zidovudine	1997

Article

Year

HIV-associated multicentric Castleman disease.

Current opinion in HIV and AIDS, 2009, Volume: 4, Issue:1

Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Asparaginase; Castleman Disease; Clinical Trials as Topic; Cytarabine; Daunorubicin; Etoposide; Ganciclovir; Herpesviridae Infections; Herpesvirus 8, Human; HIV Infections; Humans; Lymph Nodes; Rituximab; Thioguanine; Valganciclovir; Virus Replication

2009

The management of acute myeloid leukaemia (AML) in human immunodeficiency virus (HIV) infection: a case report and review.

International journal of STD & AIDS, 1997, Volume: 8, Issue:4

Topics: Adult; Anti-HIV Agents; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Cytarabine; Daunorubicin; Drug Therapy, Combination; HIV Infections; Humans; Leukemia, Myeloid, Acute; Male; Thioguanine; Zidovudine

1997

Trials

2 trial(s) available for daunorubicin and HIV Coinfection

Article	Year
Therapy of special HIV-associated diseases: HCV-HIV-co-infection and AIDS-related Kaposi's sarcoma - official satellite to the 7th European Conference on Clinical Aspects and Treatment of HIV-infection, October 23, 1999 in Lisbon, Portugal. European journal of medical research, 1999, Dec-16, Volume: 4, Issue:12 Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; Antiviral Agents; Cost-Benefit Analysis; Daunorubicin; Doxorubicin; Hepatitis C, Chronic; Herpesvirus 8, Human; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin; Sarcoma, Kaposi	1999
Patterns of lymphotropic herpesvirus viraemia in HIV-infected patients with Kaposi's sarcoma treated with highly active antiretroviral therapy and liposomal daunorubicin. AIDS (London, England), 2000, Sep-29, Volume: 14, Issue:14 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Daunorubicin; Didanosine; Drug Therapy, Combination; Herpesvirus 8, Human; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; Sarcoma, Kaposi; Stavudine; Viremia	2000

Article

Year

Therapy of special HIV-associated diseases: HCV-HIV-co-infection and AIDS-related Kaposi's sarcoma - official satellite to the 7th European Conference on Clinical Aspects and Treatment of HIV-infection, October 23, 1999 in Lisbon, Portugal.

European journal of medical research, 1999, Dec-16, Volume: 4, Issue:12

Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; Antiviral Agents; Cost-Benefit Analysis; Daunorubicin; Doxorubicin; Hepatitis C, Chronic; Herpesvirus 8, Human; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin; Sarcoma, Kaposi

1999

Patterns of lymphotropic herpesvirus viraemia in HIV-infected patients with Kaposi's sarcoma treated with highly active antiretroviral therapy and liposomal daunorubicin.

AIDS (London, England), 2000, Sep-29, Volume: 14, Issue:14

Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Daunorubicin; Didanosine; Drug Therapy, Combination; Herpesvirus 8, Human; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; Sarcoma, Kaposi; Stavudine; Viremia

2000

Other Studies

14 other study(ies) available for daunorubicin and HIV Coinfection

Article	Year
Liposomal anthracycline chemotherapy and the risk of second malignancies in patients with Kaposi's sarcoma (KS). Cancer chemotherapy and pharmacology, 2014, Volume: 74, Issue:3 Topics: Adolescent; Adult; Aged; Anthracyclines; Anti-HIV Agents; Antibiotics, Antineoplastic; Daunorubicin; Follow-Up Studies; HIV Infections; Humans; Liposomes; Male; Middle Aged; Neoplasms, Second Primary; Risk Factors; Sarcoma, Kaposi; Treatment Outcome; Viral Load; Young Adult	2014
Case Report: No Response to Liposomal Daunorubicin in a Patient with Drug-Resistant HIV-Associated Visceral Leishmaniasis. PLoS neglected tropical diseases, 2015, Volume: 9, Issue:8 Topics: Anti-HIV Agents; Antiprotozoal Agents; Coinfection; Daunorubicin; Drug Resistance; HIV Infections; HIV-1; Humans; Leishmania donovani; Leishmaniasis, Visceral; Male; Middle Aged; Treatment Failure	2015
Tuberculosis and immune thrombocytopenia. Haematologica, 2002, Volume: 87, Issue:8 Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Asparaginase; Comorbidity; Daunorubicin; HIV Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Incidence; India; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Retrospective Studies; Rifampin; Thrombocytopenia; Tuberculosis; Vincristine	2002
Mechanisms of ischemic stroke in HIV-infected patients. Neurology, 2007, Apr-17, Volume: 68, Issue:16 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Ischemia; Cardiolipins; CD4 Lymphocyte Count; Cerebral Hemorrhage; Child; Child, Preschool; Cocaine-Related Disorders; Comorbidity; Cytarabine; Daunorubicin; Female; HIV Infections; Humans; Incidence; Intracranial Arteriosclerosis; Intracranial Embolism; Male; Middle Aged; Protein S Deficiency; Retrospective Studies; Stroke; Thioguanine; Thrombophilia; Vasculitis	2007
DaunoXome data presented at international cancer meeting. Oncology (Williston Park, N.Y.), 1996, Volume: 10, Issue:6 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Daunorubicin; Doxorubicin; Drug Carriers; HIV Infections; Humans; Liposomes; Lung Neoplasms; Sarcoma, Kaposi; Vinblastine	1996
[New data: daunoxome against Kaposi sarcoma. Fifth European Conference on clinical aspects and treatment of HIV infection]. Pharmazie in unserer Zeit, 1996, Volume: 25, Issue:1 Topics: Antibiotics, Antineoplastic; Daunorubicin; HIV Infections; Humans; Sarcoma, Kaposi	1996
Mislabeling of drug for Kaposi's sarcoma rectified. The Journal of the American Osteopathic Association, 1997, Volume: 97, Issue:8 Topics: Clinical Trials, Phase III as Topic; Daunorubicin; Dose-Response Relationship, Drug; Drug Labeling; HIV Infections; Humans; Liposomes; Sarcoma, Kaposi; United States; United States Food and Drug Administration	1997
Liposomal daunorubicin is not recommended in patients with less than advanced HIV-related Kaposi's sarcoma. AIDS (London, England), 1997, Volume: 11, Issue:11 Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; Clinical Trials as Topic; Cross-Over Studies; Daunorubicin; Drug Carriers; HIV Infections; Humans; Immunocompromised Host; Liposomes; Sarcoma, Kaposi	1997
Cost-effectiveness analysis of pegylated-liposomal doxorubicin and liposomal daunorubicin treatments in patients with Kaposi's sarcoma. Acta oncologica (Stockholm, Sweden), 1999, Volume: 38, Issue:8 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cost-Benefit Analysis; Daunorubicin; Doxorubicin; Drug Carriers; Drug Costs; HIV Infections; Humans; Liposomes; Polyethylene Glycols; Randomized Controlled Trials as Topic; Retrospective Studies; Sarcoma, Kaposi; Sweden	1999
Liposomal drug targeting in the treatment of Kaposi's sarcoma. AIDS patient care and STDs, 1996, Volume: 10, Issue:6 Topics: Adult; Antibiotics, Antineoplastic; Daunorubicin; Drug Carriers; HIV Infections; Humans; Liposomes; Male; Middle Aged; Sarcoma, Kaposi; Treatment Outcome	1996
DaunoXome approved. AIDS patient care and STDs, 1996, Volume: 10, Issue:4 Topics: Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Drug Carriers; HIV Infections; Humans; Liposomes; Sarcoma, Kaposi	1996
Kaposi's sarcoma: DaunoXome approved. AIDS treatment news, 1996, May-03, Issue:no 246 Topics: Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Drug Approval; Drug Carriers; HIV Infections; Humans; Liposomes; Sarcoma, Kaposi; United States; United States Food and Drug Administration	1996
FDA approves DaunoXome as first-line therapy for Kaposi's sarcoma. Food and Drug Administration. Journal of the International Association of Physicians in AIDS Care, 1996, Volume: 2, Issue:5 Topics: Antineoplastic Agents; Daunorubicin; Drug Approval; Drug Carriers; HIV Infections; Humans; Liposomes; Quality of Life; Sarcoma, Kaposi; Treatment Outcome; United States; United States Food and Drug Administration	1996
New York ADAP to cover new AIDS drugs plus viral load testing. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1996, Volume: 10, Issue:9 Topics: Acquired Immunodeficiency Syndrome; Antibiotics, Antineoplastic; Antiviral Agents; Cytomegalovirus Infections; Daunorubicin; Drug Costs; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Insurance, Pharmaceutical Services; Lobbying; Nevirapine; New York; Pyridines; Sarcoma, Kaposi	1996